Related Experiment Video
Updated: May 9, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
Pseudomonas in augmented care: should we worry?
1Department of Microbiology, Whittington Hospital, London N19 5NF, UK.
Abstract:
The problem of Pseudomonas as a nosocomial pathogen is not new, with some authors dating its onset to the start of the antimicrobial era, although other factors, such as the growth of intensive or augmented care, have a part to play. This paper outlines the historical and environmental issues that may be associated with a potential increase in the incidence of this difficult-to-treat pathogen.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Pyelonephritis II: Diagnostic Studies and Management
Atypical Pneumonia
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Clinical Significance of Antibiotic Resistance

